MXPA05009352A - Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. - Google Patents
Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.Info
- Publication number
- MXPA05009352A MXPA05009352A MXPA05009352A MXPA05009352A MXPA05009352A MX PA05009352 A MXPA05009352 A MX PA05009352A MX PA05009352 A MXPA05009352 A MX PA05009352A MX PA05009352 A MXPA05009352 A MX PA05009352A MX PA05009352 A MXPA05009352 A MX PA05009352A
- Authority
- MX
- Mexico
- Prior art keywords
- prevention
- compositions
- treatment
- methods
- staphylococcus
- Prior art date
Links
- 241000191940 Staphylococcus Species 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La invencion se refiere a los metodos y composiciones para el tratamiento o prevencion de una infeccion por, o enfermedad provocada por la infeccion con ciertos tipos de bacterias, incluyendo en particular bacterias en las cuales una molecula tipo RAP y/o tipo TRAP juega un papel en la patogenesis. Esta incluye especies de Staphylococcus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/358,448 US7323179B2 (en) | 1997-12-19 | 2003-02-03 | Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
PCT/US2004/002679 WO2005009396A2 (en) | 2003-02-03 | 2004-01-30 | Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05009352A true MXPA05009352A (es) | 2006-03-13 |
Family
ID=34102529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05009352A MXPA05009352A (es) | 2003-02-03 | 2004-01-30 | Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. |
Country Status (10)
Country | Link |
---|---|
US (3) | US7323179B2 (es) |
EP (1) | EP1594444A4 (es) |
JP (1) | JP2007504279A (es) |
CN (1) | CN1771052A (es) |
AU (1) | AU2004258797B2 (es) |
CA (1) | CA2517600A1 (es) |
MX (1) | MXPA05009352A (es) |
NZ (1) | NZ542210A (es) |
WO (1) | WO2005009396A2 (es) |
ZA (1) | ZA200507070B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7323179B2 (en) * | 1997-12-19 | 2008-01-29 | Naomi Balaban | Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
US20080219976A1 (en) * | 1997-12-19 | 2008-09-11 | Naomi Balaban | Methods and compositions for treatment and prevention of staphylococcal infections |
US7534857B2 (en) * | 1997-12-19 | 2009-05-19 | Centegen, Inc. | Methods and compositions for the treatment and prevention of staphylococcal infections |
WO2003002163A1 (en) * | 2001-06-29 | 2003-01-09 | The Procter & Gamble Company | Absorbent article |
US20080085289A1 (en) * | 2004-09-22 | 2008-04-10 | Cindy Castado | Immunogenic Composition |
US7824691B2 (en) * | 2005-04-04 | 2010-11-02 | Centegen, Inc. | Use of RIP in treating staphylococcus aureus infections |
US20070015685A1 (en) * | 2005-04-04 | 2007-01-18 | Naomi Balaban | Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
US20070092572A1 (en) * | 2005-04-04 | 2007-04-26 | Naomi Balaban | Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
US20070009566A1 (en) * | 2005-04-04 | 2007-01-11 | Naomi Balaban | Method and apparatus for treating bacterial infections in devices |
US20070092575A1 (en) * | 2005-05-10 | 2007-04-26 | Naomi Balaban | Compositions for administering RNAIII-inhibiting peptides |
US8038990B2 (en) * | 2005-06-01 | 2011-10-18 | The Ohio State University | Compositions and methods for the prevention and removal of biofilms on inert and biological surfaces |
CN100540047C (zh) * | 2006-04-17 | 2009-09-16 | 中国人民解放军军事医学科学院基础医学研究所 | Trap蛋白在制备治疗金黄色葡萄球菌感染的药品中的应用 |
EP2032169A2 (en) * | 2006-05-23 | 2009-03-11 | Tufts University | Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap |
WO2007147098A2 (en) * | 2006-06-16 | 2007-12-21 | Tufts University | Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections |
US20090209486A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions of carbohydrates as dietary supplements |
US20090209488A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions for the treatment of exercise induced asthma |
US20090209489A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system |
US20090209487A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions of carbohydrates as dietary supplements |
US20090208588A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | GERD carbohydrate compositions |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CA2879272A1 (en) | 2012-07-16 | 2014-01-23 | Robert G.K. DONALD | Saccharides and uses thereof |
US11185555B2 (en) | 2016-04-11 | 2021-11-30 | Noah James Harrison | Method to kill pathogenic microbes in a patient |
ES2941502T3 (es) | 2016-05-13 | 2023-05-23 | 4D Molecular Therapeutics Inc | Variantes de cápsides de virus adenoasociado y procedimientos de utilización de las mismas |
CR20200165A (es) | 2017-09-20 | 2020-06-05 | 4D Molecular Therapeutics Inc | Variantes de cápsides de virus adenoasociados y métodos de uso de estas |
AU2018372235B9 (en) | 2017-11-27 | 2022-03-10 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and use for inhibiting angiogenesis |
CN112584867A (zh) | 2018-08-13 | 2021-03-30 | 聚合物工厂瑞典公司 | 树枝状纳米凝胶载体及其生产方法 |
CN113474461A (zh) | 2019-02-25 | 2021-10-01 | 诺华股份有限公司 | 治疗bietti晶体营养不良的组合物和方法 |
AU2020229085A1 (en) | 2019-02-25 | 2021-08-19 | Friedrich Miescher Institute For Biomedical Research | Compositions and methods to treat bietti crystalline dystrophy |
CN110564873B (zh) * | 2019-09-04 | 2022-09-06 | 新羿制造科技(北京)有限公司 | 一种用于鉴定表皮葡萄球菌的序列及方法 |
CN115227724B (zh) * | 2022-09-21 | 2023-03-24 | 首都医科大学附属北京友谊医院 | 缓慢葡萄球菌在制备组合物中的应用 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4034756A (en) * | 1971-01-13 | 1977-07-12 | Alza Corporation | Osmotically driven fluid dispenser |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3995651A (en) * | 1975-07-21 | 1976-12-07 | The Raymond Lee Organization, Inc. | Valve for shutting off gas flow in pipes during earthquakes |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4320759A (en) * | 1980-04-28 | 1982-03-23 | Alza Corporation | Dispenser with diffuser |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4501728A (en) * | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5019369A (en) * | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
FR2608942B1 (fr) * | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
JP3043362B2 (ja) | 1989-04-27 | 2000-05-22 | マクニール―ピーピーシー・インコーポレーテツド | タンポンへの添加剤 |
US5364838A (en) * | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US6447786B1 (en) * | 1994-10-04 | 2002-09-10 | New York University | Blocking expression of virulence factors in S. aureus |
AU3825995A (en) | 1994-10-04 | 1996-04-26 | New York University | Blocking expression of virulence factors in s. aureus |
ATE290548T1 (de) | 1996-05-22 | 2005-03-15 | Univ New York | Expressionsblockierung von virulenten faktoren in s. aureus |
US6537558B2 (en) * | 1997-03-31 | 2003-03-25 | Megan Health, Inc. | Methods of producing and using virulence attenuated poxR mutant bacteria |
US7534857B2 (en) * | 1997-12-19 | 2009-05-19 | Centegen, Inc. | Methods and compositions for the treatment and prevention of staphylococcal infections |
US20080219976A1 (en) * | 1997-12-19 | 2008-09-11 | Naomi Balaban | Methods and compositions for treatment and prevention of staphylococcal infections |
US7323179B2 (en) * | 1997-12-19 | 2008-01-29 | Naomi Balaban | Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
US6291431B1 (en) * | 1997-12-19 | 2001-09-18 | Panorama Research | Methods and compositions for the treatment and prevention of Staphylococcal infections |
US6747129B1 (en) * | 1998-09-15 | 2004-06-08 | The Regents Of The University Of California | Target of RNAIII activating protein(TRAP) |
EP1188831B1 (en) * | 1998-09-15 | 2007-12-05 | Naomi Balaban | Target of RNAIII activating protein (TRAP) |
US6475434B1 (en) * | 1998-12-07 | 2002-11-05 | Baylor College Of Medicine | Composition and methods for preventing and removing biofilm embedded microorganisms from the surface of medical devices |
US7270969B2 (en) * | 1999-05-05 | 2007-09-18 | Phylogica Limited | Methods of constructing and screening diverse expression libraries |
ATE537845T1 (de) * | 2000-10-31 | 2012-01-15 | Pr Pharmaceuticals Inc | Verfahren zur herstellung von formulierungen zur verbesserten abgabe von bioaktiven molekülen |
WO2006078318A2 (en) * | 2004-07-29 | 2006-07-27 | Novartis Vaccines And Diagnostics Inc. | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
US7824691B2 (en) * | 2005-04-04 | 2010-11-02 | Centegen, Inc. | Use of RIP in treating staphylococcus aureus infections |
US20070009566A1 (en) * | 2005-04-04 | 2007-01-11 | Naomi Balaban | Method and apparatus for treating bacterial infections in devices |
US20070015685A1 (en) * | 2005-04-04 | 2007-01-18 | Naomi Balaban | Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
US20070092572A1 (en) * | 2005-04-04 | 2007-04-26 | Naomi Balaban | Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
US20070092575A1 (en) * | 2005-05-10 | 2007-04-26 | Naomi Balaban | Compositions for administering RNAIII-inhibiting peptides |
US20070231335A1 (en) * | 2005-07-20 | 2007-10-04 | Bruce Beutler | Compositions and methods for treating Gram positive bacterial infection in a mammalian subject |
JP4138783B2 (ja) * | 2005-07-26 | 2008-08-27 | ザイオソフト株式会社 | 画像処理方法及び画像処理プログラム |
EP2032169A2 (en) * | 2006-05-23 | 2009-03-11 | Tufts University | Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap |
WO2007147098A2 (en) * | 2006-06-16 | 2007-12-21 | Tufts University | Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections |
-
2003
- 2003-02-03 US US10/358,448 patent/US7323179B2/en not_active Expired - Fee Related
-
2004
- 2004-01-30 ZA ZA200507070A patent/ZA200507070B/xx unknown
- 2004-01-30 NZ NZ542210A patent/NZ542210A/en not_active IP Right Cessation
- 2004-01-30 WO PCT/US2004/002679 patent/WO2005009396A2/en active Application Filing
- 2004-01-30 CN CNA2004800093015A patent/CN1771052A/zh active Pending
- 2004-01-30 EP EP04775755A patent/EP1594444A4/en not_active Withdrawn
- 2004-01-30 MX MXPA05009352A patent/MXPA05009352A/es active IP Right Grant
- 2004-01-30 CA CA002517600A patent/CA2517600A1/en not_active Abandoned
- 2004-01-30 JP JP2006532278A patent/JP2007504279A/ja active Pending
- 2004-01-30 AU AU2004258797A patent/AU2004258797B2/en not_active Ceased
-
2006
- 2006-05-25 US US11/440,093 patent/US20060252691A1/en not_active Abandoned
- 2006-05-26 US US11/441,229 patent/US8067015B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20060252691A1 (en) | 2006-11-09 |
US8067015B2 (en) | 2011-11-29 |
US20040072748A1 (en) | 2004-04-15 |
US7323179B2 (en) | 2008-01-29 |
US20070009569A1 (en) | 2007-01-11 |
WO2005009396A3 (en) | 2005-11-03 |
ZA200507070B (en) | 2008-12-31 |
JP2007504279A (ja) | 2007-03-01 |
CA2517600A1 (en) | 2005-02-03 |
AU2004258797B2 (en) | 2008-11-13 |
AU2004258797A1 (en) | 2005-02-03 |
CN1771052A (zh) | 2006-05-10 |
EP1594444A2 (en) | 2005-11-16 |
NZ542210A (en) | 2009-02-28 |
EP1594444A4 (en) | 2007-11-14 |
WO2005009396A2 (en) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05009352A (es) | Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. | |
TW200734344A (en) | Antibacterial agents | |
WO2007085852A3 (en) | Antimicrobial materials | |
WO2008041966A3 (en) | Broad spectrum antibacterial compounds | |
MY139124A (en) | Gyrase inhibitors and uses thereof | |
WO2006120563A3 (en) | Antibacterial agents | |
IL176289A0 (en) | New device and method for prevention of nocosomial infections | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
EP1594444A3 (en) | Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections | |
WO2009088549A3 (en) | Methods of inhibiting bacterial virulence and compounds relating thereto | |
WO2007067559A3 (en) | Antibacterial agents | |
IL189017A0 (en) | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
AP2003002942A0 (en) | New derivatives of oxazolidinones as bacterial agents | |
ATE495186T1 (de) | Antibakterielle amid-makrozyklen iv | |
WO2007089612A3 (en) | Methods and compositions for treating and preventing bacterial infections | |
UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
WO2006123164A3 (en) | Lps-binding and bactericidal cytokines and interferons | |
WO2004098500A3 (en) | CARBACEPHEM ss-LACTAM ANTIBIOTICS | |
DK1633373T3 (da) | Farmaceutisk sammensætning indeholdende glucan hidrørende fra mikroalger | |
WO2020232471A3 (en) | Methods and compositions comprising staphylococcus protein a (spa) variants | |
DK1439840T3 (da) | Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf | |
ATE420852T1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen | |
WO2005121160A3 (en) | 11, 12 cyclic thiocarbamate macrolide antibacterial agents | |
DE60115851D1 (de) | Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |